- ICH GCP
- 미국 임상 시험 레지스트리
- Search trials
임상 시험 검색 : VEGFR2
총 37 건
-
Ji Xing Pharmaceuticals (Shanghai) Co., Ltd.LENZ Therapeutics, Inc완전한
-
Stanford UniversityNational Institutes of Health (NIH)모집하지 않고 적극적으로
-
Osaka UniversityHuman Genome Center, Institute of Medical Science, University of Tokyo완전한
-
Japanese Foundation for Cancer ResearchHuman Genome Center, Institute of Medical Science, University of Tokyo완전한
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University모병
-
National Cancer Institute (NCI)완전한급성 골수성 백혈병 | 난치성 또는 재발성 고형 종양미국
-
National Cancer Institute (NCI)종료됨
-
Tokyo UniversityHuman Genome Center, Institute of Medical Science, University of Tokyo종료됨
-
Tokyo UniversityHuman Genome Center, Institute of Medical Science, University of Tokyo완전한
-
Tokyo UniversityHuman Genome Center, Institute of Medical Science, University of Tokyo완전한
-
Fukushima Medical UniversityHuman Genome Center, Institute of Medical Science, University of Tokyo완전한
-
Tokyo UniversityHuman Genome Center, Institute of Medical Science, University of Tokyo종료됨
-
Tokyo UniversityHuman Genome Center, Institute of Medical Science, University of Tokyo종료됨
-
Tokyo UniversityHuman Genome Center, Institute of Medical Science, University of Tokyo완전한
-
Tokyo UniversityHuman Genome Center, Institute of Medical Science, University of Tokyo알려지지 않은
-
Henlix, Inc종료됨
-
National Cancer Institute (NCI)종료됨전이성 암 | 전이성 흑색종 | 신장암미국
-
Fukushima Medical UniversityHuman Genome Center, Institute of Medical Science, University of Tokyo완전한
-
Fukushima Medical UniversityHuman Genome Center, Institute of Medical Science, University of Tokyo완전한
-
Fukushima Medical UniversityHuman Genome Center, Institute of Medical Science, University of Tokyo알려지지 않은
-
Beijing Dongfang Biotech Co., Ltd.Cancer Institute and Hospital, Chinese Academy of Medical Sciences아직 모집하지 않음
-
NCIC Clinical Trials GroupGlaxoSmithKline완전한
-
Exelixis완전한간세포 암벨기에, 홍콩, 대한민국, 캐나다, 프랑스, 대만, 미국, 독일, 스페인, 영국, 싱가포르, 호주, 이탈리아, 네덜란드, 폴란드, 칠면조, 아일랜드, 뉴질랜드, 루마니아
-
Shanghai Jiao Tong University School of Medicine완전한구강암 | VEGFR2 억제제 | 프로그래밍된 세포 사멸 1 억제제 | 유도 요법중국
-
Wakayama Medical UniversityHuman Genome Center, Institute of Medical Science, University of Tokyo완전한
-
Fukushima Medical UniversityHuman Genome Center, Institute of Medical Science, University of Tokyo알려지지 않은
-
Teikyo UniversityHuman Genome Center, Institute of Medical Science, University of Tokyo알려지지 않은
-
Fukushima Medical UniversityHuman Genome Center, Institute of Medical Science, University of Tokyo알려지지 않은
-
Exelixis완전한신장 세포 암종미국, 벨기에, 스페인, 대만, 캐나다, 독일, 대한민국, 프랑스, 오스트리아, 칠레, 호주, 헝가리, 러시아 연방, 이탈리아, 칠면조, 네덜란드, 스웨덴, 영국, 체코, 아일랜드, 슬로바키아, 아르헨티나, 덴마크, 핀란드, 폴란드, 포르투갈
-
Cancer Institute and Hospital, Chinese Academy...모병